BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8623443)

  • 1. Cancers in cyclosporine-treated vs azathioprine-treated patients.
    Penn I
    Transplant Proc; 1996 Apr; 28(2):876-8. PubMed ID: 8623443
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
    Hiesse C; Kriaa F; Rieu P; Larue JR; Benoit G; Bellamy J; Blanchet P; Charpentier B
    Transplant Proc; 1995 Feb; 27(1):972-4. PubMed ID: 7879250
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of malignancies in transplant recipients.
    Penn I
    Transplant Proc; 1975 Jun; 7(2):323-6. PubMed ID: 1093300
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.
    Hiesse C; Larue JR; Kriaa F; Blanchet P; Bellamy J; Benoit G; Charpentier B
    Transplant Proc; 1995 Aug; 27(4):2450-1. PubMed ID: 7652877
    [No Abstract]   [Full Text] [Related]  

  • 5. Kaposi's sarcoma in kidney transplant recipients.
    Bencini PL; Montagnino G; Tarantino A; Alessi E; Ponticelli C; Caputo R
    Arch Dermatol; 1993 Feb; 129(2):248-50. PubMed ID: 8434990
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancers after cyclosporine therapy.
    Penn I
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):276-9. PubMed ID: 3279617
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of malignancy among Egyptian kidney transplant recipients.
    Bakr MA; Sobh M; el-Agroudy A; Sally S; Fouda MA; el-Mekresh M; Moustafa F; el-Baz M; Wafa E; Ghoneim MA
    Transplant Proc; 1997 Nov; 29(7):3067-70. PubMed ID: 9365669
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumors after renal transplantation.
    Büyükpamukçu N; Karakayali H; Bilgin N
    Transplant Proc; 1996 Aug; 28(4):2317-8. PubMed ID: 8769235
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
    Batiuk TD; Barry JM; Bennett WM; Meyer MM; Tolzman D; Norman DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1391. PubMed ID: 8382860
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer after transplantation in Catalonia.
    Vilardell J; Oppenheimer F; Castelao AM; Puig JM; Cantarell MC; Solá R; Lauzurica R
    Transplant Proc; 1992 Feb; 24(1):124. PubMed ID: 1539205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pregnancy after heart and heart-lung transplantation. Apropos of 10 cases and review of the literature].
    Troché V; Ville Y; Frydman R; Fernandez H
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(6):597-605. PubMed ID: 9453976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoplasia in renal transplantation.
    Zúñiga V; Alvarez L; Diliz-P H
    Transplant Proc; 1996 Dec; 28(6):3332. PubMed ID: 8962294
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive therapy and Kaposi's sarcoma after kidney transplantation.
    Moray G; Başaran O; Yağmurdur MC; Emiroğlu R; Bilgin N; Haberal M
    Transplant Proc; 2004; 36(1):168-70. PubMed ID: 15013336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer is a complication of severe immunosuppression.
    Penn I
    Surg Gynecol Obstet; 1986 Jun; 162(6):603-10. PubMed ID: 3520906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
    Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
    Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
    Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
    Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of cancer in transplantation patients.
    Penn I
    Adv Surg; 1978; 12():155-91. PubMed ID: 367121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.